Objectives:

1. Describe the outcomes of chemotherapy regimens studies in relapsed rhabdomyosarcoma.

2. Describe the targeted and immune based therapies being studied in patients with relapsed rhabdomyosarcoma.

3. Describe the role of stem cell transplant in patients with relapsed rhabdomyosarcoma.

.

Session date: 
Thursday, December 6, 2018 - 1:00pm to 2:00pm
Speaker Name: 
Amir Siddiqui, MD
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.